Home / India / ‘Itolizumab’- Another drug approved for COVID-19 patients
‘Itolizumab’- Another drug approved for COVID-19 patients

‘Itolizumab’- Another drug approved for COVID-19 patients

NEW DELHI: The Drugs Controller General of India (DCGI) has approved Biocon’s psoriasis injection itolizumab to treat COVID-19 patients.

Biocon’s psoriasis drug is approved for “restricted emergency use” to treat patients with moderate to severe acute respiratory distress, officials said.

The approval was given after clinical trials were found satisfactory by an expert committee for treatment of cytokine release syndrome in COVID-19 patients, an official said.

Biocon, a domestic biopharmaceutical company, has been manufacturing and marketing Itolizumab, a monoclonal antibody drug, for the treatment of patients with moderate to severe chronic plaque psoriasis since 2013 under the brand name Alzumab, the health ministry said.

“This indigenous drug has now been repurposed for Covid-19,” the health ministry said in a statement.

The average cost of treatment with Itolizumab is lesser than comparable drugs which are part of the “Investigational Therapies” indicated in the Ministry of Health & Family Welfare’s Clinical Management Protocol for coronavirus.

Get Breaking news and Latest News from India and around the world on GlobalPunjabTV.net. Follow us on Facebook for more updates.

Check Also

Amarinder Slams BJP Leadership’s Criticism Of Hoshiarpur Rape-Murder Case As Political Puffery

Amarinder Slams BJP Leadership’s Criticism Of Hoshiarpur Rape-Murder Case As Pol …

CHANDIGARH, OCTOBER 24, 2020: Trashing Bharatiya Janata Party (BJP) senior leadership’s attack on his government …

Leave a Reply

Your email address will not be published. Required fields are marked *